Megumu Fukunaga Selected Research

Megumu Fukunaga Research Topics

6	Proteinuria 01/2022 - 11/2013
4	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2022 - 12/2013
4	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2020 - 11/2013
3	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022 - 12/2018
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2020 - 06/2020
2	Glomerulonephritis 06/2020 - 11/2013
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2022
1	Hyperlipoproteinemias 01/2020
1	Kidney Diseases (Kidney Disease) 01/2020
1	Lipoprotein Glomerulopathy 01/2020
1	Heart Failure 06/2015
1	Renal Insufficiency (Renal Failure) 11/2013
1	Polyarteritis Nodosa (Periarteritis Nodosa) 10/2011
1	Mononeuropathies (Mononeuritis Multiplex) 10/2011
1	Hearing Loss (Hearing Impairment) 10/2011
1	Acute Kidney Injury (Acute Renal Failure) 10/2011
1	Otitis Media 10/2011
1	Lemierre Syndrome 01/2010
1	Insulin Resistance 01/2002
1	Type 2 Diabetes Mellitus (MODY) 01/2002
1	Arteriosclerosis 01/2002

3	CreatinineIBA 10/2020 - 12/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2014 - 11/2013
2	Serum AlbuminIBA 01/2022 - 11/2013
2	Pharmaceutical PreparationsIBA 10/2020 - 12/2018
2	Apolipoproteins E (ApoE)IBA 01/2020 - 01/2018
2	ApolipoproteinsIBA 01/2020 - 01/2018
2	Apolipoprotein E2IBA 01/2020 - 01/2018
2	Methylprednisolone FDA LinkGeneric 06/2014 - 10/2011
1	SteroidsIBA 01/2022
1	LipidsIBA 01/2020
1	Oxygen (Dioxygen)IBA 06/2015
1	Prednisolone (Predate)FDA LinkGeneric 06/2014
1	Proteins (Proteins, Gene)FDA Link 12/2013
1	antiglomerular basement membrane antibodyIBA 11/2013
1	entecavir FDA Link 11/2013
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2011
1	8-epi-prostaglandin F2alphaIBA 01/2002
1	Vitamin E FDA LinkGeneric 01/2002
1	EicosanoidsIBA 01/2002
1	Troglitazone (Rezulin)FDA Link 01/2002

4	Therapeutics 12/2018 - 01/2010